Ocugen Inc said on Monday the U.S. drug regulator has lifted the clinical hold on a mid-to-late stage trial of the COVID-19 vaccine being developed by its Indian partner Bharat Biotech.
The Food and Drug Administration paused the trials of the shot, Covaxin, in April after an inspection of a Bharat Biotech facility by the World Health Organization (WHO) revealed deficiencies in the manufacturing process.
https://finance.yahoo.com/news/u-drug-regulator-lifts-clinical-112834909.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.